{
  "N/R/U": null,
  "Applicant": "AstraZeneca UK Ltd",
  "BLA Number": "761069",
  "Proprietary Name": "Imfinzi",
  "Proper Name": "durvalumab",
  "BLA Type": "351(a)",
  "Strength": "500MG/10ML (50MG/ML)",
  "Dosage Form": "Injection ",
  "Route of Administration": "Intravenous",
  "Product Presentation": "Single-Dose Vial",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "1-May-17",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": null,
  "Submission Type": "Original",
  "License Number": "2043",
  "Product Number": "1",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": "4-Dec-31"
}